Scott is the CEO of Zoe Biosciences. He previously advised Sergey Young’s Longevity Vision Fund and led Business Development & Strategic Partnerships at the Flow Research Collective. He also served on the scientific diligence team at OS Fund. Scott’s research spans epigenetics and genetics work studying tandem repeats (Sharp Lab, Mount Sinai), octopus cognition (Tse Lab, Dartmouth), in-silico autism research, and marine conservation in Madagascar. He holds a B.A. in Neuroscience (Dartmouth) and an M.S. in Biotechnology (Johns Hopkins).